KOREAPHARM Reports 3.5 Billion Won Operating Profit in H1, Up 280% Year-on-Year
KOREAPHARM's sales in the first half of this year reached 50.5 billion won, a 14.4% increase compared to the same period last year, while operating profit surged by 280.1% to 3.5 billion won.
According to KOREAPHARM on August 13, sales for the second quarter grew by 10.8% year-on-year to 25.9 billion won. During the same period, operating profit reached 2.2 billion won, marking a dramatic increase — approximately 27 times higher than the previous year — indicating a notable improvement in performance.
The robust results for the first half were driven by an increase in Contract Manufacturing Organization (CMO) volume and strong sales of in-licensed pharmaceutical products. Stable sales growth in existing Central Nervous System (CNS)-focused prescription drugs provided a foundation, while consignment and product sales utilizing state-of-the-art manufacturing facilities and distribution networks saw significant increases. Additionally, efficient sales strategies and systematic cost management helped reduce selling and administrative expenses, contributing to improved profitability.
The company is also accelerating its entry into the electronic medicine and Digital Therapeutics (DTx) sectors as part of securing mid- to long-term growth drivers. Last month, it entered into a domestic joint business agreement with Ybrain, a psychiatric electronic medicine specialist, for the EEG diagnostic system 'MindScan' and the transcranial direct current stimulation system 'MindSteam.' In addition, KOREAPHARM has signed an exclusive domestic sales agreement with Emotive for the Attention-Deficit Hyperactivity Disorder (ADHD) digital therapeutic device 'StarLucas,' and is launching an aggressive push into this market.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A KOREAPHARM representative said, "We were able to significantly improve profitability in the first half thanks to strong results from the consignment business, product sales, and efficient management of selling and administrative expenses," adding, "Based on our stable business structure in CNS therapeutics, we will actively pursue investments and partnerships to secure next-generation growth engines such as digital therapeutics."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.